Vol. 45 | No. 2 | July-December 2017Back

Open Access

Prediction of Significant Left Main Coronary Artery Disease using ST-segment Elevation in aVR Among Adult Patients with Acute Coronary Syndrome Admitted at a Tertiary Hospital from January 2011 through December 2015

Ciara Kirstine Lasaca, Walter Acusar
Dec 2017 DOI 10.69944/pjc.578191d486

More Info

Ciara Kirstine Lasaca, MD; Walter Acusar, MD 

Chinese General Hospital, Manila 

References
  1. World Health Organization. Top 20 causes of death Philippines.  World Life Expectancy Web site. http://www.worldlifeexpectancy. com/philippines-coronary-heart-disease. Published on May 2014.  Accessed August 11, 2017. 
  2. Philippine Heart Association. 2008 PHA Clinical Practice Guidelines  for the Management of Coronary Artery Disease. Quezon City:  Philippine Heart Association, 2009. 
  3. Rostloff P, Piwowarska W, Konduracka E, et al. Value of lead aVR  in the detection of significant left main coronary artery stenosis in  acute coronary syndrome. Kardiol Pol. 2005;62(2):128-35. 
  4. Mann DL, Zipes DP, Libby P, Bonow R. Braunwald’s Heart Disease:  A Textbook of Cardiovascular Medicine, Single Volume. 10th ed.  Saunders; 2015. 
  5. Yamaji H, Iwasaki K, Kusachi S, et al. Prediction of acute left main  coronary artery obstruction by 12-lead electrocardiography. ST  segment elevation in lead aVR with less ST segment elevation in lead  V(1). J Am Coll Cardiol. 2001;38(5):1348-54. 
  6. Chenniappan M, Sankar RU, Saravanan K, Karthikeyan. Lead aVR— the neglected lead. J Assoc Physicians India. 2013;61(9):650-4.
  7. Tuaño NO, Manuel RC. P-310 clinical significance of ST segment elevation in lead aVR as predictor of left main coronary  artery occlusion in acute coronary syndrome. CVD Prev Control.  2009;4(Suppl 1):S139. 
  8. Manuel RC, Abad SJG, Yabes VG. ST segment elevation in Lead  aVR as predictor of left main coronary artery lesion in acute coronary  syndrome. Phil Heart Center J. 2005;11:13-8.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.